Evan Lyall Net Worth (Estimated)
Founder at Rosebud Biosciences · YC W22
Quick answer
Evan Lyall's estimated net worth / paper wealth is $10.0M (range $7.0M–$15.0M) as of 2026.
Evan Lyall is Founder at Rosebud Biosciences (YC W22). Independent Entrepreneurial Check model estimate from public YC data.
At a glance
- Company status: Active
- Education: Stanford University
- Region: United States of America
- Industries: Healthcare, Drug Discovery and Delivery
- Team size: 3
- Website: https://rosebudbiosciences.com/
Who is Evan Lyall?
Evan Lyall is a founder at Rosebud Biosciences, a company that focuses on cannabis-based therapeutics.
Highlights:
- Stanford University
- Hale Bio
- Venture backed
About Rosebud Biosciences
Rosebud Biosciences accelerates drug development by screening drugs against organoids (micro-organs) that have the same gene mutations as the patients. We partner with therapeutics companies to screen their drugs, and we perform our own drug discovery for rare diseases that have no existing treatments. Our organoids are also fetal-like and enable discovery of novel drug targets for pediatric diseases. This...
Model inputs
- Stage: seed
- Valuation tier: fallback-seed
- Valuation note: no_discovery_sources [scale: $500k-class amount looked like a YC check, not a published seed]
- Research as-of: 2026-08-04
- Funding input: no public raise amount found; stage fallback valuation
FAQ: Evan Lyall net worth and Rosebud Biosciences valuation
What is Evan Lyall's net worth?
Evan Lyall's estimated net worth / paper wealth is $10.0M (range $7.0M–$15.0M) as of 2026. Entrepreneurial Check publishes an independent model-based estimate from public company and role data.
Evan Lyall net worth
Evan Lyall's estimated net worth / paper wealth is $10.0M (range $7.0M–$15.0M) as of 2026. This Evan Lyall net worth figure is estimated paper wealth, not a verified statement of assets.
How much is Evan Lyall worth?
Evan Lyall's estimated net worth / paper wealth is $10.0M (range $7.0M–$15.0M) as of 2026. How much Evan Lyall is worth here means estimated paper wealth from public company and role data — not financial advice.
How rich is Evan Lyall?
Evan Lyall's estimated net worth / paper wealth is $10.0M (range $7.0M–$15.0M) as of 2026. “How rich is Evan Lyall” here means estimated paper wealth from public company and role data — not verified net worth or financial advice.
Evan Lyall fortune
Evan Lyall's estimated net worth / paper wealth is $10.0M (range $7.0M–$15.0M) as of 2026. This Evan Lyall fortune figure is estimated paper wealth only, not a verified statement of assets.
Evan Lyall equity value
Evan Lyall's estimated net worth / paper wealth is $10.0M (range $7.0M–$15.0M) as of 2026. Evan Lyall equity value on this page is modeled paper wealth from estimated ownership — not a disclosed cap table or verified net worth.
What is Rosebud Biosciences valuation?
Rosebud Biosciences's estimated valuation on Entrepreneurial Check is $20.0M. Independent model output, not a verified appraisal or official mark.
What is Rosebud Biosciences post-money valuation?
Rosebud Biosciences's estimated valuation on Entrepreneurial Check is $20.0M. That figure is a modeled post-money mark when a public raise is available — not a verified appraisal or official mark.
What is Rosebud Biosciences funding?
Rosebud Biosciences funding, when a public raise is available, is a model input on this Entrepreneurial Check profile. How much Rosebud Biosciences raised is not a complete cap table — figures are estimates only.
How much did Rosebud Biosciences raise?
How much Rosebud Biosciences raised, when disclosed, informs the estimated Rosebud Biosciences valuation and founder paper-wealth figures on this page. Independent estimate only — not a complete cap table or financial advice.
How much money did Rosebud Biosciences raise?
How much money Rosebud Biosciences raised, when a public figure is available, is a model input for the estimated Rosebud Biosciences valuation on this profile. Estimates only — not a complete cap table.
What is Rosebud Biosciences series funding?
Rosebud Biosciences series funding, when a public raise is disclosed, informs the estimated Rosebud Biosciences valuation here. Not a complete financing history.
What company is Evan Lyall building?
Evan Lyall is Founder at Rosebud Biosciences, a Y Combinator-backed startup (batch W22).
What does Rosebud Biosciences do?
Rosebud Biosciences — Growing micro-organs to find new drugs
What YC batch is Evan Lyall from?
Evan Lyall is associated with Y Combinator batch W22.
Where did Evan Lyall go to school?
Public profiles associate Evan Lyall with Stanford University.
What other companies is Evan Lyall connected to?
Public associations for Evan Lyall include Hale Bio.
Where is Evan Lyall based?
Public directory data lists Evan Lyall's region as United States of America.
What industry is Evan Lyall in?
Evan Lyall is listed under Healthcare, Drug Discovery and Delivery.
How big is Rosebud Biosciences?
Public data lists Rosebud Biosciences's team size as 3.
What else is notable about Evan Lyall?
Stanford University.
Is Entrepreneurial Check affiliated with Y Combinator?
No. Entrepreneurial Check is an independent informational site and is not affiliated with, endorsed by, or sponsored by Y Combinator or the profiled companies.